Abstract
The Cleveland Clinic blood and marrow transplant program has routinely performed ‘backup’ autologous harvests in unrelated recipients with hematological malignancies in remission, lymphoma without marrow involvement and CML in chronic phase. We reviewed all adult or cord unrelated donor (URD) transplants performed from January 1995 through September 2008 to evaluate the value of this procedure. Of 130 patients who had backup harvests, 15 (11%) had their backup harvests re-infused, all for graft failure. No patients undergoing fully ablative preparation and unmanipulated or T-depleted grafts from well-matched adult donors required infusion of backup marrow. Nine of 42 patients who underwent T cell grafts from partially matched or mismatched donors, five patients undergoing partially matched ablative transplants from adult donors or cord blood, and one patient undergoing non-myeloablative transplant required infusion of their back-up harvest. Five of 15 patients who received their backup marrow are alive in CR 2–11.6 (median 7.6) years from infusion. Two of these five were bridged to a second URD transplant; the other three showed durable disease-free survival without a second allogeneic transplant. Backup harvest is unnecessary for HLA well-matched myeloablative transplants, but may be useful in patients at higher risk of graft failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anasetti C, Hansen JA . Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors. Transfus Sci 1994; 15: 221–230.
Schultz KR, Ratanatharathorn V, Abella E, Eisenbrey AB, Karanes C, Lum LG et al. Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens. Bone Marrow Transplant 1994; 13: 817–822.
Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120–2130.
Narimatsu H, Watanabe M, Kohno A, Sugimoto K, Kuwatsuka Y, Uchida T et al. High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. Bone Marrow Transplant 2008; 41: 753–756.
Chan KW, Grimley MS, Taylor C, Wall DA . Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant 2008; 42: 35–41.
Donohue J, Homge M, Kernan NA . Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 1993; 82: 1023–1029.
Dominietto A, Lamparelli T, Raiola AM, Van Lint MT, Gualandi F, Berisso G et al. Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation. Blood 2002; 100: 3930–3934.
Nemunaitis J, Singer JW, Buckner CD, Durnam D, Epstein C, Hill R et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 1990; 76: 245–253.
Min CK, Kim DW, Lee JW, Min WS, Kim CC . Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation. Acta Haematol 2000; 104: 185–192.
Wolff SN . Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545–552.
van Walraven SM, Heemskerk MB, Lie JL, Barge RM, Cornelissen JJ, Egeler RM et al. The importance of identifying a back-up donor for unrelated stem cell transplantation. Bone Marrow Transplant 2005; 35: 437–440.
Davies SM, Weisdorf DJ, Haake RJ, Kersey JH, McGlave PB, Ramsay NK et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 73–77.
Mehta J, Powles R, Singhal S, Horton C, Treleaven J . Outcome of autologous rescue after failed engraftment of allogeneic marrow. Bone Marrow Transplant 1996; 17: 213–217.
Pottinger B, Walker M, Campbell M, Holyoake TL, Franklin IM, Cook G . The storage and re-infusion of autologous blood and BM as back-up following failed primary hematopoietic stem-cell transplantation: a survey of European practice. Cytotherapy 2002; 4: 127–135.
Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008; 14: 748–758.
Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A et al. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2008; 42: 739–742.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stotler, C., Bolwell, B., Sobecks, R. et al. Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?. Bone Marrow Transplant 45, 49–52 (2010). https://doi.org/10.1038/bmt.2009.95
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.95
Keywords
This article is cited by
-
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience
Annals of Hematology (2023)
-
Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP
Bone Marrow Transplantation (2021)